Advanced Search
Current and Breaking News for Professionals, Consumers and Media

Click here to learn how to advertise on this site and for ad rates.

Research Author: Yale University Last Updated: Apr 23, 2009 - 8:29:17 PM



Yale Researchers Find New Way to Fix Faulty Genes Sickle Cell Anemia, Other Inherited Diseases Targeted
By Yale University
Aug 28, 2008 - 11:29:45 AM

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Email Newsletter
For Email Marketing you can trust
Email this article
 Printer friendly page
(HealthNewsDigest.com) - New Haven, Conn. - Yale University researchers have found a new method to create lasting genetic changes within human cells, opening up the possibility of new treatments for inherited diseases like sickle cell anemia.

The researchers corrected a specific defect within a human gene that causes the blood disorder thalassemia, researchers reported in a study to be published online in the journal Proceedings of the National Academy of Sciences USA. The disease affects production of hemoglobin, the molecule in red blood cells that carries oxygen to the body.

Scientists in the laboratory of Peter Glazer, professor and chair of the Department of Therapeutic Radiology and professor of genetics at the Yale School of Medicine were also able to slip a sort of genetic repair kit into blood stem cells. In theory, repairs to these hematopoietic progenitor cells would enable the body to produce healthy red blood cells indefinitely

Genetic diseases like thalassemia and sickle cell anemia are particularly problematic to treat because defects are carried within DNA of every cell in the body. Glazer's laboratory team, headed by Joanna Chin, created a series of artificial DNA molecules designed to bind to specific locations in the genome. These molecules, called triplex-forming oligonucleotides, trigger the DNA's own repair system, resulting in potentially permanent correction of genetic defects.

In the past, gene-based therapies have met with limited successes in part because of difficulties finding ways to insert a new version of an entire gene into human cells and to have that new gene stay active for a long time. Glazer said their technique avoids some of these pitfalls because it employs oligonucleotides that are short, synthetic DNA molecules that are easier to insert into cells and do not require viruses for their delivery. Importantly, the new technique fixes the defect in the existing gene so it can be expressed in a natural manner, Glazer noted.

Other researchers on the study from Yale contributing to the study were Jean Y. Kuan, Pallavi. S. Lonkar and Diane Krause. Researchers from the National Institute on Aging, University of Kansas, University of Copenhagen in Denmark, and University of North Carolina also were contributing authors.

The work was funded by the National Institutes of Health.

www.HealthNewsDigest.com

Top of Page

HealthNewsDigest.com

Research
Latest Headlines


+ How the Brain Controls Our Limb Movement
+ Yale Scientists Shed Colorful Light On Novel Proteins
+ Promising New Medicines In The Pharmaceutical Pipeline
+ Sorting Out What Makes Proteins Clump Together
+ Compound Created at OSU Could Become Important New Antidepressant
+ Same-Sex Attraction - Potential Evolutionary Role
+ Melatonin Precursor Stimulates Growth Factor Circuits in Brain
+ Many Hospitals Fail To Lower Infection Risk Despite Lifesaving Checklist
+ Fish Oil Becomes Most Popular Dietary Supplement
+ Identify Brain Protein for Synapse Development



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions